Quantcast
Last updated on June 1, 2012 at 19:03 EDT

News - Gamida Cell Ltd.

2010-11-25 02:01:00

TEL AVIV, Israel, November 25, 2010 /PRNewswire-FirstCall/ -- Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit") announced today that, further to its announcement dated September 13, 2010, it has successfully closed the transaction with Enter Holdings 1 Ltd.

2010-09-13 11:15:00

TEL-AVIV, Israel, September 13, 2010 /PRNewswire-FirstCall/ -- Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit") announced today that it has entered into a share purchase agreement (the "Agreement") with Enter Holdings 1 Ltd.

2010-03-16 12:57:00

TEL AVIV, Israel, March 16, 2010 /PRNewswire-FirstCall/ -- Elbit Imaging (NASDAQ: EMITF) ("Elbit Imaging" "Company") announced today that its wholly-owned subsidiary, Elbit Medical Ltd., has filed today a draft prospectus (the "Prospectus"), with the Israel Securities Authority , in respect of its proposed initial public offering of shares on the Tel Aviv Stock Exchange. Upon the issuance of the Prospectus, the Company will hold its medical holdings and bio-tech (InSightec - approximately 62%, and Gamida Cell - approximately 27%; both on a fully diluted basis) through Elbit Medical Ltd ., which was formed as part of the Company's ongoing restructuring and streamlining of business activities throughout the Company's divisions. The shares offered in the IPO will not be registered under the U.S. Securities Act of 1933 and will not be offered or sold in the United States . This press release shall not constitute an offer to sell or the solicitation of an offer to buy any shares.

2010-02-10 06:39:00

TEL AVIV, Israel, February 10 /PRNewswire-FirstCall/ -- - StemEx Study is Enrolling Patients at Cord Blood Transplant Centers in the U.S., Spain, Italy, Hungary and Israel. Elbit Imaging Ltd.

2010-02-02 03:54:00

TEL AVIV, Israel, February 2 /PRNewswire-FirstCall/ -- Elbit Imaging (NASDAQ: EMITF) ("Elbit Imaging" "Company") announced today that it intends to restructure its bio-tech and medical holdings (InSightec - 60%, and Gamida Cell - 28%; both on a fully diluted basis) under a wholly-owned Elbit Imaging subsidiary and to offer shares of such subsidiary in a public offering on the Tel Aviv Stock Exchange ("IPO").

More News (14 articles) »